Platelet Function Testing and Genotyping for Tailoring Treatment in Complex PCI Patients
Dual antiplatelet therapy (DAPT), comprising aspirin and a P2Y12 receptor inhibitor, is considered the cornerstone of treatment in patients who have undergone percutaneous coronary intervention (PCI). Patients with complex PCI (C-PCI) constitute a special PCI subpopulation, characterized by increase...
Guardado en:
Autores principales: | Athanasios Moulias, Angeliki Papageorgiou, Dimitrios Alexopoulos |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2fd8f0f78aa043a8bcd54b6fd753ba85 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment
por: Despoina-Rafailia Benetou, et al.
Publicado: (2021) -
Guide extension catheter in complex PCI – Our experience
por: Rajesh Natuva, et al.
Publicado: (2021) -
Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention
por: Dimitrios Alexopoulos, et al.
Publicado: (2020) -
Antithrombotic Therapy in Complex Percutaneous Coronary Intervention Patients Requiring Chronic Anticoagulation
por: Despoina-Rafailia Benetou, et al.
Publicado: (2021) -
Using Pharmacogenetic Testing to Tailor Warfarin Therapy: The Singapore Experience and What the Future Holds
por: Grace Shu-wen Chang, et al.
Publicado: (2020)